About the journal
The Lancet Haematology is a journal published by Elsevier BV in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 6,300 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 2451-9960 · 2352-3026
- Country
- Netherlands
- Access
- Not open access / not declared
- Declared publication charge
- 6,300 USD
- Declared peer-review model
- peer_review
- Official website
- https://www.journals.elsevier.com/the-lancet-haematology
Index listings
- MEDLINE · 2015-01-01
- PUBMED · 2014-10-01
- Indexing
- MEDLINE · PUBMED
- APC
- 6,300 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 62 days received→accepted — computed from PubMed (n=81)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
2003
Last recorded publication year
2026
h-index
133
i10-index
686
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 62%
- ORCID iDs in current deposits
- 2%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101643584
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Hemoglobinopathies and Related Disorders
- Hemoglobinopathies and Related Disorders
Show all subjects (50)
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Acute Lymphoblastic Leukemia research
- CAR-T cell therapy research
- Acute Lymphoblastic Leukemia research
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- CAR-T cell therapy research
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Venous Thromboembolism Diagnosis and Management
- Venous Thromboembolism Diagnosis and Management
- Iron Metabolism and Disorders
- Iron Metabolism and Disorders
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Platelet Disorders and Treatments
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Blood groups and transfusion
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Blood transfusion and management
- CNS Lymphoma Diagnosis and Treatment
- Blood donation and transfusion practices
- CNS Lymphoma Diagnosis and Treatment
- Blood transfusion and management
- Blood donation and transfusion practices
- Hemophilia Treatment and Research
- Viral-associated cancers and disorders
- Viral-associated cancers and disorders
- Blood Coagulation and Thrombosis Mechanisms
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
- Cutaneous lymphoproliferative disorders research
- Erythropoietin and Anemia Treatment
- Erythropoietin and Anemia Treatment
- Childhood Cancer Survivors' Quality of Life
- Childhood Cancer Survivors' Quality of Life
- Cutaneous lymphoproliferative disorders research
- Atrial Fibrillation Management and Outcomes
- Atrial Fibrillation Management and Outcomes
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ